© 2024 Alpha Spread Limited. All Rights Reserved.
www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.
You don't have any saved screeners yet
Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.
Good morning, ladies and gentlemen. Welcome to the ATS Automation First Quarter Conference Call and Webcast. I would like to remind you that this call is being recorded on August 14, 2019, at 10 a.m. Eastern Time. [Operator Instructions]I would now like to turn the call over to Stewart McCuaig, Vice President, General Counsel of ATS.
Thanks, operator, and good morning, everyone. Your main hosts today are Andrew Hider, Chief Executive Officer of ATS; and Maria Perrella, Chief Financial Officer.Before we begin, I'm required to make the following statement respecting forward-looking information, which is made on behalf of the ATS and all its representatives on this call.The oral statements made on this call will contain forward-looking information. The actual results could differ materially from a conclusion, forecast or projection in the forward-looking information. Certain material factors or assumptions were applied in drawing a conclusion or making a forecast or projection as reflected in the forward-looking information.Additional information about the material factors that could cause actual results to differ materially from the conclusion, forecast or projection in the forward-looking information and the material factors or assumptions that were applied in drawing a conclusion or making a forecast or projection, as reflected in the forward-looking information, are contained in the ATS's filings with the Canadian Provincial Securities regulators.Now it's my pleasure to turn the call over to Andrew.
Thank you, Stewart. Good morning, ladies and gentlemen, and thank you for joining us. Our first quarter performance features growth in bookings and revenues, continued margin expansion, the advancement of our ABM and contributions from our recent acquisitions. We finished the quarter with record order backlog. This morning, I am going to speak to you about our Q1 performance and outlook. Maria will then provide her report.Starting with our Q1 financial value drivers. Bookings were record $423 million, up 18% over last year. Organic growth accounted for half the increase, the other half coming from Comecer and KMW. Both of our recent acquisitions performed well. We booked a number of large programs during the quarter, including a life sciences program for a medical device application with an existing customer, and several large programs in transportation in North America and Europe, all with repeat customers. Our sales and operations teams continue to execute well. Q1 revenues were $339 million, up 13% over the last year. Excluding acquisitions, our organic revenue growth was 4%. Our Q1 adjusted EBIT margin was 11%.Moving to our outlook. We ended the quarter with record order backlog of $982 million, up 24% over the last year. This provides us with a good base of business to drive growth for the remainder of the year.Looking at our funnel, life sciences continues to be strong, and we are seeing good opportunities in medical devices, pharma and radiopharma. Life sciences represents over 50% of our backlog, and we are well aligned to drive penetration in this market. Life sciences has positive industry dynamics, high barriers to entry, including stringent regulation and high consequence of failure. These characteristics are complementary to our capabilities, which includes high speed, high precision solutions across a number of applications.EV activity remains healthy and represents the majority of our transportation funnel. Our proven success in EV, including battery module and pack assembly and E-motor assembly, positions us well to capitalize on the transportation market shift.In consumer and energy, we continue to pursue niche opportunities, where our technologies align well with the value required by our customers. As I have stated in the past, I expect our customers will continue to exercise caution and be thorough in making their capital investment decisions, which could lead to variability in order bookings from quarter-to-quarter. We also continue to monitor the impact of trade disputes on customer activities and our supply chain, which has added another variable to our customers' investment decisions. On after sales services, customer receptivity is positive, and we continue to see favorable trends adjudging service sales to our CapEx fitness.Q1 after sales service bookings and revenues both increased at double-digit rates over the last year and our funnel for services remained strong. We have made investments in after sales services over the past several years, opened infrastructure to grow and develop the business and an innovation to drive market leadership as with the recent launch of our IoT solutions.We remain focused on growing the strategic area of our business, adjudging recurring revenues and contributes to our margin expansion initiatives.Moving to the ATS Business Model. We are continuing to embed the ABM and how we do business every day. At Comecer, we introduced training on ABM fundamentals and held our first problem-solving event. Globally, we conducted 15 Kaizen Events, which address areas such as operations, project management, tune resources and finance. Just a couple of highlights from this last quarter. One division reduced lead time on a specific assembly process by over 50% through standardizing its workflow, streamlining processes and improving daily visual management.Another division reduced a key operational process by 20% through value stream mapping, implementing standards in their process and eliminating waste. Our ABM boot camps and weekly lean training sessions are ongoing in driving advancements of the ABM throughout the business.Employee feedback is positive as our people are engaged in making improvements in their day-to-day activities. The pace of advancement is encouraging, and we have many opportunities ahead for continued improvements that I expect will support our margin expansion plans.Turning to our investment activities. During the quarter, we broke ground on the expansion of one of our facilities in Cambridge. This expansion led capacity for our life sciences business and dedicated space for innovation teams. Our innovation activities are ongoing. Early in the first quarter, we launched Illuminate Manufacturing Intelligence, our connected factory management IoT platform that customers use to maximize their overall equipment effectiveness, productivity and quality.We continue to review our capital allocation strategy, including internal investment opportunities, acquisitions and share buybacks to drive long-term shareholder value.Moving to Comecer. ATS life sciences business coupled with Comecer creates a sizable platform that we expect to grow. Integration of fundamental business activities is progressing very well. We have built a pipeline that pursues with combined businesses of working together and specific opportunities that capitalize on a strong and positive momentum created in the market since the acquisition.Sales groups have been aligned internally with improved capacity for Comecer in North America. We are continuing to work -- our work to develop integrated service offerings and develop a joint go-to-market strategy for the aseptic fill-and-finish market. Customer receptivity is positive, and we are confident that revenue synergies will be achieved.Integration of administrative activities is expected to be largely complete in the next few months. Joint initiatives between the supply chain groups are underway to drive cost-saving synergies, which we are working to achieve over the next 12 to 24 months.In summary, we are focused on our value-creation strategy, build, grow and expand. We are off to a good start to the year with solid growth in both bookings and revenues. We have a record order backlog, and we are well positioned to drive growth in fiscal 2020. We are focused on driving continuous improvement in all aspects of our business through our ABM. Our balance sheet remains strong, which we will continue to put to work through internal investment, innovation and strategic M&A as well as share repurchases when appropriate, all with the goal to continue to create long-term shareholder value.Now I'll turn the call over to Maria.
Thank you, Andrew. We continue to make good progress on our strategy as our Q1 performance demonstrated. Our operations performed well with the continued year-over-year improvement in our key financial value drivers, bookings, revenues and adjusted earnings from operations margin, both with and without the acquired companies. Working capital as a percentage of revenue has increased this quarter, however, remains below 15%. Q1 fiscal '20 has a full quarter of Comecer and KMW results as compared to none in Q1 in fiscal 2019. This morning, I'll discuss Q1 results and our balance sheet.I'll start with operating results. This is the first time ATS has achieved quarterly bookings greater than $400 million. Q1 bookings were $423 million, up 18% from $358 million last year. As you heard, half of the increase came organically and the other half came from acquired companies. We are pleased with this level of bookings growth, considering the uncertainty in general economic conditions. We saw good bookings in both our life sciences and transportation end markets. Q1 revenues of $339 million included $27 million from Comecer and KMW. Excluding acquired companies, revenues of $312 million were 4% higher than last year's $300 million, reflecting growth in our backlog and increased services revenues.Q1 revenues were down from $349 million in Q4 due to the varying periods of performance on some of our large dollar programs, which impact time to revenue. We will continue to have quarter-to-quarter variability. However, growth in backlog will provide us with a solid base to generate year-over-year revenue growth for the fiscal year.Strong bookings in Q1 increased backlog to a record $982 million compared to last year's period end order backlog of $789 million. More comparably, this also represents a 9% increase over Q4 backlog of $904 million, which included acquired backlog. In the quarter, we had a good mix of orders ranging in size, period of performance and end markets.Looking forward, Q2 fiscal '20 revenues are estimated to be in the 30% to 35% range of backlog. This is an estimated range that takes into account several variables, including the composition of our backlog at the end of the quarter, which includes a few longer performance period programs, one in Q1, an estimates of the impact of the lower labor revenues due to thick vacation periods, primarily in Europe, and our estimates of in quarter orders, which may be booked and converted to revenue in the same quarter.Moving to margins. Over the last year, we have improved our gross margins, progressing from 26% in Q1 and Q2 fiscal '19, and then to 26.6% by the end of Q4 and now, 27% in Q1 fiscal '20.Note that approximately 20 basis points of the improvement in gross margin is due to IFRS 16, with the remaining 80 basis points due to improved program execution and operational utilization supported by the ongoing implementation of the ABM and our focus on continuous improvements.Excluding acquisition-related amortization expenses in both periods, Q1's SG&A was $49.9 million, or an $8 million increase compared to last year Q1 of $41.9 million.SG&A has increased over the prior year due primarily to the addition of Comecer and KMW SG&A of approximately $4 million, and due to increased employee costs, sales-related expenses and other costs to support organic growth.Q1 adjusted earnings from operations of $38 million were 11.2% of revenues compared to $32.6 million or 10.9% last year. The adoption of IFRS 16 provided the majority of the increase. In Q1, higher SG&A costs largely offset higher gross margins. As we've stated in the past, we do expect to improve our operating leverage and expect this will happen as we generate higher revenues from our backlog, which will be supported by and drive leverage of our cost structure. Both KMW and Comecer's results were on plan and integration is progressing well.Moving to the balance sheet. Our noncash working capital as a percentage of revenue increased in Q1 to 12.4%, up from 7.1% in Q4 and 10.6% in Q1 last year. Timing of deposits, program milestones and payment of accrued liabilities caused the increase. Cash used in operations was $40.4 million in Q1 compared to last year when we had usage of $400,000.At the end of the quarter, our net debt position was $244 million compared to effectively 0 last year. We continue to have strong liquidity with cash on hand of $155 million, and our credit facility of which approximately $642 million is available.In Q1 fiscal '20, we generated adjusted earnings per share of $0.25 compared to $0.22 last year. The 14% year-over-year increase was due primarily to increased revenues. Our effective tax rate was 23.5% in the quarter. Going forward, our effective tax rate is expected to continue to be in the range of 25% of pretax earnings.In summary, we had a good start to fiscal '20 and are well positioned for the balance of the year with a record $982 million of backlog. We will continue to focus on the development of the ABM, the integration of acquired companies and other initiatives to drive margin expansion.Our funnel remains well diversified with a mix of programs and enterprise solutions. We have a strong balance sheet with available credit, which will support our objective of profitable growth.Now we'd like to open the call for your questions. Operator, could you please provide instructions to our listeners? Thank you.
[Operator Instructions] And your first question comes from Cherilyn Radbourne from TD Securities.
Congratulations on that bookings number. First question relates to the bookings. I guess the strength was somewhat surprising, in that there weren't any large orders that were press released during the quarter. So I am just curious if that was because there were a number of large programs booked in the quarter that just simply, on an individual basis, fell short of the threshold for disclosure?
Cherilyn, so in the quarter we did have a number of large programs. And as we say typically to have large bookings quarters, we need orders and orders which range in size above $20 million, so $20 million, $30 million and $40 million and we had 4 such orders in the quarter and both range in size from $20 million to $30 million, 3 of them were in transportation and 1 of them was in life sciences.
Okay. And then we noticed in looking at the income statement that part sales looked like they were particularly strong in the quarter. Is there any color that you can provide in that area?
Cherilyn, we had seen continued strength in this area, and we're very pleased with the progress we've made. We've talked often about the infrastructure that we've continued to expand on and the investments we've made. And the team for executing it performed well within the quarter and as importantly, the funnel for the year remains healthy in this area. I often state and will continue to state, there is a lot of work to do between now and year-end and as we move forward, but the team is executing very well here.
[Operator Instructions] Your next question comes from Justin Keywood from GMP Securities.
Just a follow-up on transportation bookings, if I heard correctly, there was 3 new wins in the quarter. And were those from existing customers or new?
Justin, all 3 were from existing customers.
Okay. And in general, how are you seeing the EV trend progress? Are customers still a bit hesitant there or is it progressing better than expected?
So what we've seen on EV trend, Justin is, when we press our customers', the investment that they're driving towards in this space is going to continue. And 1 of the 3 orders was on EV base, it was a repeat customer, it was a repeat order in a similar production line. The other 2 were models shifts in our traditional auto, which we do segment out, and we focus on specific areas. But what we've seen macro is EV is continuing to invest, where we do see some dynamics is by region that we've seen a bit more proactive approach in Europe and in North America, they are aligning around it and there are good opportunities in that area.
Okay. That's good to hear. And just more generally, you mentioned some potential conservatism by customers due to trade or tariff fear. Could you just maybe elaborate on that? Are you seeing this as a possible near-term risk? Or is it potentially an opportunity for ATS?
Yes. So just to be very clear on my comment is, customers will continue and do continue to look at their investments and ensure that they are exercising caution in their investment. That -- what we've seen so far, that has not changed. And therefore, when we look at the dynamics, and let's just look at the leading indicators for a second. First, very strong bookings quarter. Second, when we look at the markets that we were driving towards, the market trends in those specific markets are things we look at in detail. And third, we visit and part of my job is to -- you know I personally visit many of these customers to understand their investment plans and where they're taking their business. And we feel comfortable where we are today and our leading indicators remain positive. So all that to be said, yes, there's a lot of macro trends. Areas we're focused on, we're continuing to see a strong funnel to support our business and what we stated around growth.
Your next question comes from Maxim Sytchev from National Bank Financial.
Do you mind me providing a bit more color in terms of the progress on Comecer integration?
Max, so we are -- if I were to take a step back and look at the progression of integration, we are exactly on plan. And what we're pleased about is, there has been some early indication of positive areas that we're focused on. For instance, we've talked about the sales synergies within the business and for one example, in Q1, we have booked an order with Comecer as a joint effort with ATS, other customer that they had lost in the past. Well, that customer didn't move forward because Comecer couldn't support the business out of North America. And so early indications and also early evidence that the joint efforts around our sales synergy are and remain positive. That said, it is still early days, and we are learning, we are working with the business to make sure that we're achieving the full potential, but it's still early days.
Okay. That's fair enough. And then maybe just a quick question for Maria. Just given the fact, I mean, obviously backlog has grown fairly significantly. The working capital that's needed to support this extended backlog duration, should we think about a different percentage? I mean I know that you're reiterating below the 15% versus revenues, but like incrementally, should we expect some sort of creep there or that should normalize as the year progress?
I would start by saying that our target is, in all possibilities, to be below 15%. With the increase in backlog, we don't expect that target to change. We're still targeting to be below 15% working capital as a percentage of revenue. And in Q1, we did see an increase versus compared to fiscal '19 and that just has to do with timing of milestone payments and deposits. We expect for that working capital percentage to come down, but -- and it will be a function of timing of these programs that are in backlog. But we don't expect a creep as a result of what is in our backlog.
Okay. So there's no structural change dynamic? I guess that's kind of the bottom line, right?
No, no structural change. No.
Okay. And maybe Andrew, if you don't mind if I can sneak one last one. In terms of M&A opportunities, what are you guys seeing on the horizon? Maybe comment around multiples and the desire to sell on the part of the company's potential you're talking to?
Sure. So to start, funnel is helping on the M&A potential, and you know our work very well, just to watch the market's strategic rationale. How we are going to integrate and operate in our ATS team and follow -- and our approach on this has been very solid and very strong. Multiple wise, we are not seeing a huge differentiation in the multiple store or healthy multiples for good businesses and therefore, and I often state this, we will drive and have a very disciplined approach. And that's why we often talk about cultivation, ensuring we're talking to the right businesses because when we add an organization and we want to really have a -- have them to be part of the family, we want to maximize its potential. But overall, it's still viewed as a healthy area, and we're going to continue to exercise cautiously, but yet be very proactive in our approach.
[Operator Instructions] Your next question comes from Cherilyn Radbourne with TD Securities.
Just a follow-up from me and I guess, it's a bit of a two-parter. So last quarter, you had made a comment that in EV market, North American customers were a little slower to pull the trigger on investments versus their counterparts. So I was kind of curious if there were any bookings that sort of slipped out over the last quarter into Q2? But then conversely, part B, in this quarter's MD&A, there is a comment about bookings in energy being down year-over-year as a result of the timing of customer decisions on some larger opportunities. So on the other side, I was wondering if anything sort of slipped out of Q1 and potentially into Q2?
So as we step back on the total business and we often restate that timing is variable, it aligns with our customers. And we see -- and as we've talked in the past, we see that within a quarter, we see that within a year. So oftentimes, we're very focused on the timing with our customers. More specifically, as we look into EV, we haven't seen the trend change. Our view of the market in Europe is continuing to be like we stated, a bit more bullish on the EV investment. In North America, we see the opportunities and we're aligned well with the opportunities. But they have been slightly delayed. I would say timing is almost what we expect, but yet we're aligning. And when we step back on an ATS point of view, we cannot provide the highest level of our value with our customers through either situations, whether they move forward and they want to drive to have the product in the market in a very quick space or whether they're going to analyze, ensure they got the right products. So both planned our situation well for the EV. From energy, nothing here. It's -- as we stated, it's a niche area. The business, we're really ensuring that we provide value for the customers in the orders we had in-house and when we see opportunities that align well with what we can provide in the market, we're going to execute.
Your next question comes from Robert Caldwell from Richardson. [Operator Instructions] Mr. Hider, there are no further questions at this time.
Thanks, operator. And thank you, everyone, for joining us today. I look forward to reporting our second quarter results in November. Take care.
This concludes today's conference call. You may now disconnect.